Narrative review on ferroptosis-targeting strategies for glioblastoma modulation
New Brain Tumor Strategy Targets Iron to Boost Immune Attack
This narrative review synthesizes mechanisms and strategies for targeting ferroptosis in glioblastoma.
This new approach uses the tumor's own iron problem to help the body's immune system destroy cancer cells more effectively.
Systematic review evaluates Treg depletion and reprogramming strategies for glioblastoma in adults
A New Tactic to Outsmart the Brain’s Most Aggressive Cancer
This systematic review examined interventions targeting regulatory T cells in adults with glioblastoma.
Researchers are designing new weapons that could help a patient’s own immune system finally attack a deadly brain tumor.
Phase 1/2 trial shows RT + bevacizumab + olaptesed pegol extends PFS and OS in unmethylated GBM
New Drug Combo Slows Brain Cancer Growth
A Phase 1/2 expansion arm in six patients with newly-diagnosed, unmethylated GBM found that adding bevacizumab to radiotherapy and olaptesed…
Adding a second drug to stop blood vessel growth gives patients with brain cancer more time before the disease returns.
DOC1021 vaccine with SOC showed favorable 12-month OS in newly-diagnosed glioblastoma patients
A New Brain Cancer Vaccine Shows Promise Where Other Treatments Fail
This Phase I clinical study evaluated DOC1021 (dubodencel) integrated with standard of care (SOC) in newly-diagnosed and recurrent glioblast…
A new type of personalized vaccine, added to standard treatment, was safe and linked to significantly longer survival for patients with a no…
PINK1 expression quantified by IHC in adults with newly diagnosed IDH-wild type glioblastoma multiforme
A Simple Brain Tumor Test Could Predict Your Treatment Path
This prospective observational cohort study evaluated PINK1 expression in adults (18+ years) with newly diagnosed IDH-wild type glioblastoma…
A specific protein in glioblastoma tissue could forecast survival odds, helping patients plan care even though the test is not available yet…
Multi-omics integration identifies candidate genes and cell-type-specific effects in glioma
Could genetic clues finally pinpoint the right cells to target in deadly brain tumors?
This computational analysis integrated GWAS, bulk tissue, and single-cell multi-omics data to investigate glioma.
A new analysis of genetic maps shows deadly brain tumors drive growth by increasing communication between support cells and nerve cells.
PARPi combinations show no significant clinical improvement in adult patients with glioblastoma
PARPi drugs show limited benefit for glioblastoma due to brain barriers
This systematic review evaluated poly-ADP-ribose polymerase inhibitors (PARPi) combined with standard therapy for adult patients with gliobl…
A systematic review examined PARP inhibitors used with standard treatments for adult glioblastoma patients.
Radiomics models predict IDH mutation status and survival in glioma patients across discovery and validation cohorts
Can scans predict glioma risks without surgery? New models show promise but need more proof
This multicenter cohort study evaluated radiomics-based machine learning models in 638 glioma patients to predict isocitrate dehydrogenase (…
Computer scans can spot dangerous brain tumor patterns without surgery, but accuracy drops when tested on new patients, so doctors still nee…
Deep learning QTMnet shows potential for glioma grading versus traditional 2CXM model
AI method shows promise for classifying brain tumor severity in small study
A study of 30 glioma patients compared a deep neural network-based perfusion estimation method (QTMnet) to a traditional two-compartment exc…
New AI analysis of brain scans outperformed traditional methods at telling the difference between low and high severity tumors in a small te…
Case report describes intracranial WHO Grade II ependymoma with rare lipomatous metaplasia
Doctors report rare case of brain tumor containing fat tissue in young man
A case report and literature review describes a 28-year-old male with an incidentally discovered intracranial mass.
A rare brain tumor containing fat tissue was found in a young man, prompting doctors to review similar cases to help identify this unique va…
Bibliometric analysis identifies 100 most-cited articles on proton therapy for glioma
Where is the research on proton therapy for brain tumors heading?
A bibliometric analysis of 100 highly-cited articles on proton therapy for glioma found the United States leads in publications, with Massac…
A new analysis of the top 100 studies on proton therapy for brain tumors shows the United States leads the field, with Massachusetts General…
Bibliometric analysis maps 4.3-fold rise in elderly glioma research, highlights MGMT focus
Why is brain tumor research for older adults lagging behind? A new analysis reveals a critical gap
A bibliometric analysis of 1,299 publications found a 4.3-fold increase in research on elderly glioma from 2001 to 2025, with the U.S., Ital…
Glioma research for older adults lags behind because studies focus on younger patients, leaving a critical gap in treating aggressive tumors…
Research across Cancer
Related studies from across the Cancer family.
Review of glioma organoid models for mechanistic discovery and therapy development
Finally Lab-Grown Brain Models Could Speed Up Glioma Treatments
This narrative review summarizes glioma organoid model systems for studying tumor-neural interactions. It concludes these models provide a f…
• Tiny lab-grown brains mimic real tumor behavior better than old methods • Kids and adults fighting deadly brain cancers like glioblastoma …
Preoperative model predicts functional outcomes after glioma resection using clinical and MRI variables
AI predicts brain tumor recovery before surgery begins
This retrospective cohort study of 552 adults undergoing first resection of supratentorial contrast-enhancing glioma evaluated a preoperativ…
A new AI tool uses MRI scans to predict how well brain tumor patients recover after surgery and helps doctors plan care better.
Case report reviews capmatinib off-label use in two patients with radiation-induced MET-fusion glioma
Capmatinib Shows Promise Against Rare Brain Tumors
This case report with literature review describes off-label capmatinib use in two patients with radiation-induced gliomas harboring MET fusi…
A drug used for lung cancer is now helping some children with rare, deadly brain tumors live longer, even when standard treatments fail.
Recurrence patterns in high-grade glioma after standard chemoradiotherapy: a retrospective review
Why tumors grow back inside the radiation beam, not just at the edges
This retrospective single-center review of 41 patients with high-grade glioma found that central recurrence was the most common pattern (36.…
New data shows brain tumors often return in the middle of the radiation zone, suggesting biology, not just targeting errors, drives failure.
GSC-associated gene signature predicts survival in adult and pediatric high-grade glioma patients
New Brain Tumor Test Predicts Survival More Accurately
This cohort study evaluated a GSC-associated gene signature involving the FAM86B1/FAM86B2 axis in adult and pediatric high-grade glioma pati…
A new model uses specific genes to predict how long patients might live with aggressive brain tumors.
Unsupervised clustering of glioma RNAseq data shows diagnostic and prognostic potential
AI-powered analysis reveals hidden brain tumor subtypes with survival links
This unsupervised clustering analysis of public TCGA glioma RNAseq data (n=692) found high diagnostic concordance and prognostic separation.
A new AI method sorted brain tumors into groups that matched clinical diagnoses 91% of the time and uncovered subtypes tied to survival.
Review of STING agonists for high-grade and diffuse midline glioma discusses systemic toxicity and delivery constraints
New Brain Drug Target Could Wake Up the Immune System
This narrative review examines the potential of STING agonists, cyclic dinucleotides, and related compounds for treating high-grade glioma a…
A new brain drug target aims to wake up the immune system's defenses against dangerous, hard-to-treat tumors that hide from the body's natur…
CyberKnife-SRT for brainstem glioma shows median overall survival of 20.9 months in retrospective cohort
CyberKnife May Help Rare Brain Tumor Patients Live Longer
This retrospective cohort study of 54 patients with brainstem glioma treated with CyberKnife-SRT found a median overall survival of 20.9 mon…
A new radiation technique called CyberKnife helps rare brainstem glioma patients live longer by sparing healthy tissue while treating the tu…
Locoregional CAR T-cell delivery reduces severe adverse events in high-grade glioma patients
Could a new way to deliver brain cancer therapy make it safer and more effective?
A meta-analysis of 14 clinical trials involving 194 high-grade glioma patients found locoregional CAR T-cell delivery was associated with re…
Delivering brain cancer therapy directly to the tumor instead of through the bloodstream cuts severe side effects by more than 60% and shows…
Questions about Glioma
How does the immune system interact with Glioma cells in the brain?
Glioma cells suppress immune attack by recruiting regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages, while also triggering ferroptosis via CD8+ T cell signals.
Full answer →Can RNA data help doctors predict the outcome of my Glioma diagnosis?
Yes, RNA data can help predict glioma outcomes by revealing molecular subtypes linked to survival, as shown in studies using unsupervised clustering of RNAseq data.
Full answer →Does having a high mutation burden help Glioma patients live longer on treatment?
No, high mutation burden does not help glioma patients live longer on treatment; it is linked to poor survival and low immunotherapy response.
Full answer →Can AI models predict how well my Glioma will respond to radiotherapy?
Yes, AI models that combine radiomics, dosiomics, and clinical data can predict radiotherapy response in glioma, but they are not yet standard clinical tools.
Full answer →